Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

Therapeutic Advances in Vaccines

Volumn 2, Issue 2, 2014, Pages 56-66

  Chyu, Kuang Yuh ^a   Shah, Prediman K ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Immune response; Immunization

Indexed keywords

EID: 84902159185     PISSN: 20510136     EISSN: None     Source Type: Journal    
DOI: 10.1177/2051013613514327     Document Type: Article

References (103)

1. Afek, A., George, J., Shoenfeld, Y., Gilburd, B., Levy, Y., Shaish, A. et al. (1999) Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice. Pathobiology 67: 19–25.
2. Almanzar, G., Ollinger, R., Leuenberger, J., Onestingel, E., Rantner, B., Zehm, S. et al. (2012) Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions. J Autoimmun 39: 441–450.
3. Alving, C., Swartz, G., Jr, Wassef, N., Ribas, J., Herderick, E., Virmani, R. et al. (1996) Immunization with cholesterol-rich liposomes induces anticholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation. J Lab Clin Med 127: 40–49.
4. Ameli, S., Hultgardh-Nilsson, A., Regnstrom, J., Calara, F., Yano, J., Cercek, B. et al. (1996) Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 16: 1074–1079.
5. Andersson, J., Libby, P. and Hansson, G. (2010) Adaptive immunity and atherosclerosis. Clin Immunol 134: 33–46.
6. Armitage, G. (2000) Periodontal infections and cardiovascular disease – how strong is the association? Oral Dis 6: 335–350.
7. Ausiello, C., Palazzo, R., Spensieri, F., Fedele, G., Lande, R., Ciervo, A. et al. (2005) 60-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune response. J Biol Regul Homeost Agents 19: 136–140.
8. Banchereau, J. and Palucka, A. (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5: 296–306.
9. Beck, J., Pankow, J., Tyroler, H. and Offenbacher, S. (1999) Dental infections and atherosclerosis. Am Heart J 138: S528-S533.
10. Bergmark, C., Wu, R., de Faire, U., Lefvert, A. and Swedenborg, J. (1995) Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15: 441–445.
11. Betjes, M., Litjens, N. and Zietse, R. (2007) Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant 22: 3298–3303.
12. Binder, C. (2010) Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol 30(Suppl. 1): S56-S60.
13. Binder, C. (2012) Naturally occurring IgM antibodies to oxidation-specific epitopes. Adv Exp Med Biol 750: 2–13.
14. Binder, C., Hartvigsen, K., Chang, M., Miller, M., Broide, D., Palinski, W. et al. (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114: 427–437.
15. Binder, C., Horkko, S., Dewan, A., Chang, M., Kieu, E., Goodyear, C. et al. (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9: 736–743.
16. Briles, D., Forman, C., Hudak, S. and Claflin, J. (1982) Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156: 1177–1185.
17. Buhlin, K., Gustafsson, A., Pockley, A., Frostegard, J. and Klinge, B. (2003) Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 24: 2099–2107.
18. Caligiuri, G., Khallou-Laschet, J., Vandaele, M., Gaston, A., Delignat, S., Mandet, C. et al. (2007) Phosphorylcholine-targeting immunization reduces atherosclerosis. J Am Coll Cardiol 50: 540–546.
19. Cesena, F., Dimayuga, P., Yano, J., Zhao, X., Kirzner, J., Zhou, J. et al. (2012) Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE–/– mice. Atherosclerosis 220: 59–65.
20. Chang, M., Bergmark, C., Laurila, A., Horkko, S., Han, K., Friedman, P. et al. (1999) Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidationspecific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A 96: 6353–6358.
21. Chou, M., Fogelstrand, L., Hartvigsen, K., Hansen, L., Woelkers, D., Shaw, P. et al. (2009) Oxidationspecific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119: 1335–1349.
22. Chyu, K., Nilsson, J. and Shah, P. (2011) Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine. Discov Med 11: 403–412.
23. Chyu, K. and Shah, P. (2013) Can we vaccinate against atherosclerosis? J Cardiovasc Pharmacol Ther 13 September (Epub ahead of print).
24. Chyu, K., Zhao, X., Dimayuga, P., Zhou, J., Li, X., Yano, J. et al. (2012) CD8 T cells mediate the atheroprotective effect of immunization with an ApoB-100 peptide. PLoS One 7: e30780.
25. Chyu, K., Zhao, X., Reyes, O., Babbidge, S., Dimayuga, P., Yano, J. et al. (2005) Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (–/–) mice. Biochem Biophys Res Commun 338: 1982–1989.
26. da Cunha, A. and Weiner, H. (2012) Induction of immunological tolerance by oral anti-CD3. Clin Dev Immunol 2012: 425021.
27. Davidson, M., Maki, K., Umporowicz, D., Wheeler, A., Rittershaus, C. and Ryan, U. (2003) The safety and immunogenicity of a CETP vaccine in healthy adults. Atherosclerosis 169: 113–120.
28. Dunoyer-Geindre, S., Kwak, B., Pelli, G., Roth, I., Satta, N., Fish, R. et al. (2007) Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques. Thromb Haemost 97: 129–138.
29. Erkkila, A., Narvanen, O., Lehto, S., Uusitupa, M. and Yla-Herttuala, S. (2005) Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease. Atherosclerosis 183: 157–162.
30. Faria-neto, J., Chyu, K., Li, X., Dimayuga, P., Ferreira, C., Yano, J. et al. (2006) Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 189: 83–90.
31. Fredrikson, G., Andersson, L., Soderberg, I., Dimayuga, P., Chyu, K., Shah, P. et al. (2005) Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Autoimmunity 38: 171–179.
32. Fredrikson, G., Bjorkbacka, H., Soderberg, I., Ljungcrantz, I. and Nilsson, J. (2008) Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies. J Intern Med 264: 563–570.
33. Fredrikson, G., Hedblad, B., Berglund, G., Alm, R., Ares, M., Cercek, B. et al. (2003a) Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. Arterioscler Thromb Vasc Biol 23: 872–878.
34. Fredrikson, G., Soderberg, I., Lindholm, M., Dimayuga, P., Chyu, K., Shah, P. et al. (2003b) Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol 23: 879–884.
35. Freigang, S., Horkko, S., Miller, E., Witztum, J. and Palinski, W. (1998) Immunization of LDL receptordeficient mice with homologous malondialdehydemodified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18: 1972–1982.
36. Friedman, P., Horkko, S., Steinberg, D., Witztum, J. and Dennis, E. (2002) Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration. J Biol Chem 277: 7010–7020.
37. Fukumoto, M., Shoji, T., Emoto, M., Kawagishi, T., Okuno, Y. and Nishizawa, Y. (2000) Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 20: 703–707.
38. Gaofu, Q., Jun, L., Xin, Y., Wentao, L., Jie, W., Xiuyun, Z. et al. (2005) Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo. J Cardiovasc Pharmacol 45: 591–598.
39. George, J., Afek, A., Gilburd, B., Blank, M., Levy, Y., Aron-Maor, A. et al. (1998a) Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 98: 1108–1115.
40. George, J., Afek, A., Gilburd, B., Levkovitz, H., Shaish, A., Goldberg, I. et al. (1998b) Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138: 147–152.
41. George, J., Harats, D., Gilburd, B., Afek, A., Shaish, A., Kopolovic, J. et al. (2000a) Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102: 1822–1827.
42. George, J., Harats, D. and Shoenfeld, Y. (2000b) Autoimmunity in atherosclerosis. The role of autoantigens. Clin Rev Allergy Immunol 18: 73–86.
43. George, J., Shoenfeld, Y., Afek, A., Gilburd, B., Keren, P., Shaish, A. et al. (1999) Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol 19: 505–510.
44. Gero, S., Gergely, J., Jakab, L., Szekely, J., Virag, S., Farkas, K. et al. (1959) Inhibition of cholesterol atherosclerosis by immunisation with beta-lipoprotein. Lancet 2: 6–7.
45. Grosso, D., Ferderbar, S., Wanschel, A., Krieger, M., Higushi, M. and Abdalla, D. (2008) Antibodies against electronegative LDL inhibit atherosclerosis in LDLr–/– mice. Braz J Med Biol Res 41: 1086–1092.
46. Grundtman, C., Kreutmayer, S., Almanzar, G., Wick, M. and Wick, G. (2011) Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol 31: 960–968.
47. Grundtman, C. and Wick, G. (2011) The autoimmune concept of atherosclerosis. Curr Opin Lipidol 22: 327–334.
48. Habets, K., van Puijvelde, G., van Duivenvoorde, L., van Wanrooij, E., De, V., Tervaert, J. et al. (2010) Vaccination using oxLDL-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc Res 85: 622–630.
49. Halme, S., Syrjala, H., Bloigu, A., Saikku, P., Leinonen, M., Airaksinen, J. et al. (1997) Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease. Eur Heart J 18: 1095–1101.
50. Hartvigsen, K., Chou, M., Hansen, L., Shaw, P., Tsimikas, S., Binder, C. et al. (2009) The role of innate immunity in atherogenesis. J Lipid Res 50(Suppl.): S388-S393.
51. Hauer, A., van Puijvelde, G., Peterse, N., de Vos, P., van Weel, V., van Wanrooij, E. et al. (2007) Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol 27: 2050–2057.
52. Herbin, O., it-Oufella, H., Yu, W., Fredrikson, G., Aubier, B., Perez, N. et al. (2012) Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 32: 605–612.
53. Hermansson, A., Ketelhuth, D., Strodthoff, D., Wurm, M., Hansson, E., Nicoletti, A. et al. (2010) Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med 207: 1081–1093.
54. Horkko, S., Bird, D., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G. et al. (1999) Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103: 117–128.
55. Hung, I., Leung, A., Chu, D., Leung, D., Cheung, T., Chan, C. et al. (2010) Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 51: 1007–1016.
56. Iribarren, C., Folsom, A., Jacobs, D., Gross, M., Belcher, J. and Eckfeldt, J. (1997) Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities. Arterioscler Thromb Vasc Biol 17: 1171–1177.
57. Kilic, A. and Mandal, K. (2012) Heat shock proteins: pathogenic role in atherosclerosis and potential therapeutic implications. Autoimmune Dis 2012: 502813.
58. Klingenberg, R., Ketelhuth, D., Strodthoff, D., Gregori, S. and Hansson, G. (2012) Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in apoE(–)/(–) mice. Immunobiology 217: 540–547.
59. Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G., Strodthoff, D., Rudling, M. et al. (2010) Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigenspecific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 30: 946–952.
60. Lamontagne, F., Garant, M., Carvalho, J., Lanthier, L., Smieja, M. and Pilon, D. (2008) Pneumococcal vaccination and risk of myocardial infarction. CMAJ 179: 773–777.
61. Lehtimaki, T., Lehtinen, S., Solakivi, T., Nikkila, M., Jaakkola, O., Jokela, H. et al. (1999) Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol 19: 23–27.
62. Li, J., Zhao, X., Zhang, S., Wang, S., Du, P. and Qi, G. (2011) ApoB-100 and HSP60 peptides exert a synergetic role in inhibiting early atherosclerosis in immunized apoE-null mice. Protein Pept Lett 18: 733–740.
63. Li, S., Kievit, P., Robertson, A., Koluman, G., Li, X., von Wachenfeldt, K. et al. (2013) Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques. Molecular Metabolism 2: 256–269.
64. Long, J., Lin, J., Yang, X., Yuan, D., Wu, J., Li, T. et al. (2012) Nasal immunization with different forms of heat shock protein-65 reduced highcholesterol- diet-driven rabbit atherosclerosis. Int Immunopharmacol 13: 82–87.
65. Lu, X., Chen, D., Endresz, V., Xia, M., Faludi, I., Burian, K. et al. (2010) Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice. Atherosclerosis 212: 472–480.
66. Lundberg, A. and Hansson, G. (2010) Innate immune signals in atherosclerosis. Clin Immunol 134: 5–24.
67. Mandal, K., Jahangiri, M. and Xu, Q. (2004) Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev 3: 31–37.
68. Mandal, K., Jahangiri, M. and Xu, Q. (2005) Autoimmune mechanisms of atherosclerosis. Handb Exp Pharmacol (170): 723–743.
69. Mao, D., Kai, G., Gaofu, Q., Zheng, Z., Li, Z., Jie, W. et al. (2006) Intramuscular immunization with a DNA vaccine encoding a 26-amino acid CETP epitope displayed by HBc protein and containing CpG DNA inhibits atherosclerosis in a rabbit model of atherosclerosis. Vaccine 24: 4942–4950.
70. Maron, R., Sukhova, G., Faria, A., Hoffmann, E., Mach, F., Libby, P. et al. (2002) Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of lowdensity lipoprotein receptor-deficient mice. Circulation 106: 1708–1715.
71. Matsuura, E., Kobayashi, K., Inoue, K., Lopez, L. and Shoenfeld, Y. (2005) Oxidized LDL/ beta2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus 14: 736–741.
72. Mayr, M., Kiechl, S., Willeit, J., Wick, G. and Xu, Q. (2000) Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102: 833–839.
73. Movahed, M. (1999) Infection with Chlamydia pneumoniae and atherosclerosis: a review. J S C Med Assoc 95: 303–308.
74. Nicoletti, A., Kaveri, S., Caligiuri, G., Bariety, J. and Hansson, G. (1998) Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 102: 910–918.
75. Nicolo, D., Goldman, B. and Monestier, M. (2003) Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody. Arthritis Rheum 48: 2974–2978.
76. Nilsson, J., Calara, F., Regnstrom, J., Hultgardh- Nilsson, A., Ameli, S., Cercek, B. et al. (1997) Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. J Am Coll Cardiol 30: 1886–1891.
77. Olofsson, P., Jatta, K., Wagsater, D., Gredmark, S., Hedin, U., Paulsson-Berne, G. et al. (2005) The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol 25: e113–e116.
78. Palinski, W., Miller, E. and Witztum, J. (1995) Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A 92: 821–825.
79. Palucka, K. and Banchereau, J. (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12: 265–277.
80. Persson, L., Boren, J., Nicoletti, A., Hansson, G. and Pekna, M. (2005) Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E low-density lipoprotein receptor mice via the complement system. Clin Exp Immunol 142: 441–445.
81. Pierides, C., Bermudez-Fajardo, A., Fredrikson, G., Nilsson, J. and Oviedo-Orta, E. (2013) Immune responses elicited by apoB-100-derived peptides in mice. Immunol Res 56: 96–108.
82. Rittershaus, C., Miller, D., Thomas, L., Picard, M., Honan, C., Emmett, C. et al. (2000) Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol 20: 2106–2112.
83. Salonen, J., Yla-Herttuala, S., Yamamoto, R., Butler, S., Korpela, H., Salonen, R. et al. (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883–887.
84. Sasaki, N., Yamashita, T., Takeda, M., Shinohara, M., Nakajima, K., Tawa, H. et al. (2009) Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 120: 1996–2005.
85. Schiopu, A., Bengtsson, J., Soderberg, I., Janciauskiene, S., Lindgren, S., Ares, M. et al. (2004) Recombinant human antibodies against aldehydemodified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation 110: 2047–2052.
86. Schiopu, A., Frendeus, B., Jansson, B., Soderberg, I., Ljungcrantz, I., Araya, Z. et al. (2007) Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(–/–) mice. J Am Coll Cardiol 50: 2313–2318.
87. Shaw, P., Horkko, S., Chang, M., Curtiss, L., Palinski, W., Silverman, G. et al. (2000) Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105: 1731–1740.
88. Shoenfeld, Y., Sherer, Y., George, Y. and Harats, D. (2001) beta 2-glycoprotein I in human and murine atherosclerosis. Isr Med Assoc J 3: 85–87.
89. Siriwardena, A., Gwini, S. and Coupland, C. (2010) Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched casecontrol study. CMAJ 182: 1617–1623.
90. Tseng, H., Slezak, J., Quinn, V., Sy, L., Van den Eeden, S. and Jacobsen, S. (2010) Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 303: 1699–1706.
91. van Es, T., van Puijvelde, G., Foks, A., Habets, K., Bot, I., Gilboa, E. et al. (2009) Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 209: 74–80.
92. van Puijvelde, G., van Es, T., van Wanrooij, E., Habets, K.L., de Vos, P., van Der, Z. et al. (2007) Induction of oral tolerance to HSP60 or an HSP60- peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 27: 2677–2683.
93. van Wanrooij, E., de Vos, P., Bixel, M., Vestweber, D., van Berkel, T. and Kuiper, J. (2008) Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice. Cardiovasc Res 78: 590–596.
94. Van Leeuwen, M., Kemna, M., de Winther, M., Boon, L., Duijvestijn, A., Henatsch, D. et al. (2013) Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice. PLoS One 8: e68039.
95. Wigren, M., Kolbus, D., Duner, P., Ljungcrantz, I., Soderberg, I., Bjorkbacka, H. et al. (2010) Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J Intern Med 269: 546–556.
96. Xu, Q., Dietrich, H., Steiner, H., Gown, A., Schoel, B., Mikuz, G. et al. (1992) Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12: 789–799.
97. Xu, Q., Metzler, B., Jahangiri, M. and Mandal, K. (2012) Molecular chaperones and heat shock proteins in atherosclerosis. Am J Physiol Heart Circ Physiol 302: H506–H514.
98. Yan, Z. and Hansson, G. (2007) Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 219: 187–203.
99. Yother, J., Forman, C., Gray, B. and Briles, D. (1982) Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody. Infect Immun 36: 184–188.
100. Yuan, Z., Kishimoto, C., Sano, H., Shioji, K., Xu, Y. and Yokode, M. (2003) Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion. Am J Physiol Heart Circ Physiol 285: H899–H906.
101. Zelkha, S., Freilich, R. and Amar, S. (2010) Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontol 54: 207–221.
102. Zhang, Y., Xiong, Q., Hu, X., Sun, Y., Tan, X., Zhang, H. et al. (2012) A novel atherogenic epitope from Mycobacterium tuberculosis heat shock protein 65 enhances atherosclerosis in rabbit and LDL receptor-deficient mice. Heart Vessels 27: 411–418.
103. Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A. and Hansson, G. (2001) LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21: 108–114.